Skip to main content
logo
Vertex Pharmaceuticals Incorporated (ETR:VX1)
Germany flag Germany · Delayed Price · Currency is EUR
352.85
-6.20 (-1.73%)
Oct 10, 2025, 5:35 PM CET

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Trikafta / Kaftrio Revenue
10.39B10.24B
Log In
Log In
Log In
Upgrade
Symdeko / Symkevi Revenue
--
Log In
Log In
Log In
Upgrade
Orkambi Revenue
--
Log In
Log In
Log In
Upgrade
Kalydeco Revenue
--
Log In
Log In
Log In
Upgrade
Casgevy Revenue
54.60M10.00M
Log In
Log In
Log In
Upgrade
Other Product Revenue
785.00M781.50M
Log In
Log In
Log In
Upgrade
Net Product Revenue
11.39B11.02B
Log In
Log In
Log In
Upgrade
Other Collaborative and Royalty Revenue
--
Log In
Log In
Log In
Upgrade
Revenue (Other)
-11.23B-11.03B
Log In
Log In
Log In
Upgrade
Revenue (Total)
11.39B11.02B
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Other Collaborative and Royalty Revenue
--
Log In
Log In
Log In
Upgrade
United States Product Revenue
7.03B6.68B
Log In
Log In
Log In
Upgrade
Outside of United States Product Revenue
4.36B4.34B
Log In
Log In
Log In
Upgrade
Revenue (Total)
11.39B11.02B
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.